The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 Elements
ChemMedChem · 17.05.2024 · 19 (10)
DOI: 10.1002/cmdc.202300645 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 28.02.2024. Verfasst von María Gil-Moles und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza, Pedro Cerbuna 12, 5000…. Hauptthemen laut MEDLINE: Coordination Complexes, Pyridines, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Gobierno de Aragón, European Union, NextGenerationEU.
Abstract (Originalsprache)
Terpyridine‐based complexes with group 11 metals emerge as potent metallodrugs in cancer therapy. This comprehensive review focuses on the current landscape of anticancer examples, particularly highlighting the mechanisms of action. While Cu(II) complexes, featuring diverse ancillary ligands, dominate the field, exploration of silver and gold species remains limited. These complexes exhibit significant cytotoxicity against various cancer cell lines with a commendable selectivity for non‐tumorigenic cells. DNA interactions, employing intercalation and groove binding, are pivotal and finely tuned through terpyridine ligand functionalization. In addition, copper complexes showcase nuclease activity, triggering apoptosis through ROS generation. Despite silver‘s high affinity for nitrogen donor atoms, its exploration is relatively sparse, with indications of acting as intercalating agents causing DNA hydrolytic cleavage. Gold(III) compounds, overshadowing gold(I) due to stability concerns, not only intercalate but also induce apoptosis and disrupt the mitochondrial membrane. Further investigations are needed to fully understand the mechanism of action of these compounds, highlighting the necessity of exploring additional biological targets for these promising metallodrugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza, Pedro Cerbuna 12, 50009, Zaragoza, Spain.
- Departamento de Química, Centro de Investigación de Síntesis Química (CISQ), Universidad de la Rioja, Complejo Científico-Tecnológico, 26004, Logroño, Spain.
ORCID-Profile: M Concepción Gimeno
Förderung
- Agencia Estatal de Investigación
- Gobierno de Aragón
- European Union, NextGenerationEU
Zitieren
APA
Gil-Moles, M., & Concepción Gimeno, M. (2024). The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 Elements. ChemMedChem, 19(10). https://doi.org/10.1002/cmdc.202300645
Vancouver
Gil-Moles M, Concepción Gimeno M. The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 Elements. ChemMedChem. 2024;19(10). doi:10.1002/cmdc.202300645
BibTeX
@article{GilMoles2024,
author = {Gil-Moles, María and Concepción Gimeno, M},
title = {The Therapeutic Potential in Cancer of Terpyridine‐Based Metal Complexes Featuring Group 11 Elements},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {10},
doi = {10.1002/cmdc.202300645}
}
EUVIMED